INmune Bio files U.S. patent for cell therapy platform
INmune Bio files U.S. patent for cell therapy platform
INmune Bio files U.S. patent for cell therapy platform
Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.